Fexofenadine
Product Images NDC 55648-982

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Fexofenadine (NDC 55648-982). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Fexofenatabotc Figure 01)

Carton (Fexofenatabotc Figure 01)
This is a medicine called Fexofenadine HCI Tablets, USP. It's used to temporarily relieve symptoms such as runny nose, itchy, watery eyes, sneezing, and itching of the nose or throat due to hay fever or other respiratory allergies. It is available for children ages 6 years and older. The tablets contain 30mg of antihistamine and should not be used by people who are allergic to it or any of its components. Dosage instructions should be followed closely for adults, children, and elderly people. If you have kidney disease, consult a doctor before using it. The drug should not be taken with aluminum or magnesium antacids or fruit juices. Overdose can have serious consequences. Questions or comments can be directed to the manufacturer's toll-free number.*
FDA Label Image

Blister (Fexofenatabotc Figure 02)

Blister (Fexofenatabotc Figure 02)
This is a description of Fexofenadine HCI Tablet, USP for Allergy relief, manufactured by Wockhardt USA LLC and containing 60 mg of the active ingredient. It is sold under NDC number 64679-982-08 and has a 12-hour duration of action. The lot number and expiration date are included in the text as "Lot Exp." The rest of the text is not-related gibberish.*
FDA Label Image

Carton (Fexofenatabotc Figure 03)

Carton (Fexofenatabotc Figure 03)
Fexofenadine HCI Tablets, USP 60 mg is an antihistamine used to temporarily relieve upper respiratory allergy symptoms such as runny nose, itchy, watery eyes, sneezing or itching of the nose or throat. The recommended dose for adults and children 12 years of age and over is one tablet with water every 12 hours. It is advised not to take more than two tablets in 24 hours or to take it with fruit juices or antacids containing aluminum or magnesium. People with kidney disease are recommended to consult a doctor before use. It is not for use by children under 12 years of age and pregnant or breastfeeding women should also consult a doctor before use. If an allergic reaction occurs, stop use immediately and seek medical attention.*
FDA Label Image

Label (Fexofenatabotc Figure 04)

Label (Fexofenatabotc Figure 04)
This is a description of an allergy medication called Fexofenadine HCI, in tablet form with 180mg of the active ingredient. It is used to temporarily relieve symptoms of upper respiratory allergies due to hay fever such as sneezing, runny nose and watery eyes. The medication comes in a package of 30 tablets and is labeled as non-drowsy with original prescription strength. It is important not to take more than directed, nor to take it at the same time as aluminum or magnesium antacids or with fruit juices. This medication should be stopped if an allergic reaction occurs, and medical help should be sought immediately. People with kidney disease or who are pregnant or breastfeeding should consult a healthcare professional before use. This medication should be stored in a safe, dry place at room temperature.*
FDA Label Image

Carton (Fexofenatabotc Figure 05)

FDA Label Image

Label (Fexofenatabotc Figure 06)

Label (Fexofenatabotc Figure 06)
This is a description of Fexofenadine HCI tablets, which is an antihistamine. It provides temporary relief from symptoms associated with hay fever or other respiratory allergies, such as a runny nose, sneezing, watery eyes, itching of the nose or throat. The tablets are 180 mg each and are used by individuals aged 12 years and above, and only one tablet may be taken per day. The product should not be used by individuals who have ever had an allergic reaction to the product or any of its ingredients, and a doctor should be consulted before utilization by individuals with kidney disease or those above 65 years. The product should be stored at 20° 10.25°C (68°to 77°) and kept out of reach of children due to the risk of overdose. The inactive ingredients include colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone K-30, talc, and titanium dioxide. The product is distributed by Wockhardt USA LLC.*
FDA Label Image

Carton (Fexofenatabotc Figure 07)

FDA Label Image

Carton (Fexofenatabotc Figure 08)

FDA Label Image

Blister (Fexofenatabotc Figure 09)

Blister (Fexofenatabotc Figure 09)
Children's Fexofenadine HCI Tablet is a 30mg, 12-hour allergy relief medicine that is distributed by Wockhardt USA LLC in Parsippany, New Jersey. The packaging includes the lot number and expiration date, as well as the NDC code of 64679-744-08.*
FDA Label Image

Blister (Fexofenatabotc Figure 10)

Blister (Fexofenatabotc Figure 10)
This is a product description for Fexofenadine HCI, a tablet for allergy relief. Each tablet contains 180 mg of medication and offers 24 hours of relief. The tablets are distributed by Wockhardt USA LLC in Parsippany, NJ. The lot and expiration date are also provided on the packaging, but some of the text is not readable.*
FDA Label Image

Carton (Fexofenatabotc Figure 11)

Carton (Fexofenatabotc Figure 11)
Fexofenadine HCI Tablets, USP 180 mg ALLERGY 24Hour are an antihistamine used to temporarily relieve symptoms due to hay fever or other upper respiratory allergies, including runny nose, itchy, watery eyes, sneezing, and itching of the nose or throat. The tablets are to be taken with water by adults and children 12 years of age and over once a day, with no more than 1 tablet taken in 24 hours. The product contains inactive ingredients such as lactose monohydrate and magnesium stearate, and should not be used by children under 12 years of age, except under the advice and supervision of a doctor. In case of overdose or an allergic reaction, medical attention should be sought immediately. If pregnant or breastfeeding, a health professional should be consulted before use.*
FDA Label Image

Carton (Fexofenatabotc Figure 12)

Carton (Fexofenatabotc Figure 12)
Fexofenadine HCI Tablets, USP 180 mg is a non-drowsy antihistamine medication that is designed to temporarily relieve the symptoms of indoor and outdoor allergies such as runny nose, sneezing, itchy, watery eyes, and itchy nose or throat due to hay fever. The drug should be taken once a day with water, and adults and children above 12 years old should not take more than one tablet within 24 hours. However, children under 12 years old should not take the medication at all. Individuals with kidney disease are advised to consult their doctor before use, and the drug should not be used if one has ever had an allergic reaction to it or its ingredients. The medication should not be taken with aluminum or magnesium antacids, and fruit juices should also be avoided. Fexofenadine HCI Tablets should be stored at 20° to 25°C and protected against excessive moisture. If you are pregnant or breastfeeding, consult a health practitioner before using the drug. Inactive ingredients in the medication include lactose monohydrate, titanium dioxide, hypromellose, talc, and colloidal silicon dioxide, among others.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.